XML 38 R29.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF RESERVED SHARES

  

      
Exercise of issued and future grants of stock options     15,114  
Conversion of convertible debt     246,004  
Exercise of stock warrants     329,479  
Total     590,597  
SCHEDULE OF STOCK OPTION ACTIVITY

The following represents a summary of the options granted to employees and non-employee service providers that were outstanding at September 30, 2024, and changes during the nine-month period then ended:

 

 

   Shares   Weighted–
Average
Exercise
Price
   Range of
Exercise
Price
   Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2023   7,978   $1,760.26    $256.80 — $2,565.00    7.06 
Granted                
Expired                
Forfeited   (1,239)  $743.77    $256.80 — $2,565.00     
Total outstanding – September 30, 2024   6,739   $1,947.06    $256.80 — $2,565.00    6.22 
Exercisable (vested)   6,153   $2,103.52    $256.80 — $2,565.00    6.08 
Non-Exercisable (non-vested)   586   $305.69    $256.80 — $620.00    7.71 
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The Company recorded share-based compensation expense and classified it in the unaudited condensed consolidated statements of operations as follows:

  

   2024     2023     2024   2023 
   For the Three Months Ended September 30,   For the Nine Months Ended September 30, 
   2024   2023   2024   2023 
General and administrative  $27,208   $73,384   $94,264   $881,365 
Research and development       40,417    24,680    140,674 
Total  $27,208   $113,801   $118,944   $1,022,039 
Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the activity in the common stock equity classified compensatory warrants for the nine months ended September 30, 2024:

  

   Common Stock 
   Shares   Weighted– Average
Exercise
Price
   Range of
Exercise Price
   Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2023   2,381   $534.44    $36.50—$1,270.25    1.25 
Granted                 
Exercised                
Expired   (520)  $1,033.15    $1,033.15—$1,033.15     
Forfeited                
Total outstanding –September 30, 2024   1,861   $351.88    $6.50—$1,270.25    4.50 
Exercisable   1,861   $351.88    $6.50—$1,270.25    0.72 
Non-Exercisable                 

 

The following table summarizes the activity in the common stock equity classified compensatory warrants for the nine months ended September 30, 2023:

 

   Common Stock
   Shares   Weighted– Average
Exercise
Price
   Range of
Exercise Price
   Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2022   3,581   $455.88   $66.00 — $1,270.25    1.73 
Exercised                
Expired   (1,200)  $300.00   $300.00 — $300.00     
Forfeited                
Total outstanding – September 30, 2023   2,381   $534.44   $66.00 — $1,270.25    1.50 
Exercisable   2,381   $534.44   $66.00 — $1,270.25    1.50 
Non-Exercisable                
Non Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the non compensatory equity classified warrant activity for the nine months ended September 30, 2024:

  

   Common Stock
   Shares  

Weighted– Average

Exercise Price

   Range of Exercise Price   Weighted– Average Remaining Life (Years) 
Total outstanding – December 31, 2023   50,141   $36.50   $36.50 — $36.50    4.47 
Granted   70,021   $6.81   $6.50 — $7.80    4.54 
Pre-funded investor warrants issued   239,456   $0.05   $0.05 — $0.05    n/a 
Exercised   (31,998)  $13.00   $13.00 — $13.00     
Reclassified to liabilities   (2,314)  $6.50   $6.50 — $6.50    4.41 
Expired                
Forfeited                
Total outstanding – September 30, 2024   325,306   $6.50   $0.00 — $6.50    n/a 
Exercisable   309,287   $6.50   $

0.00 — $6.50 

    n/a 
Non-Exercisable   16,019   $7.80   $7.80 — $7.80    4.94 

 

 

The following table summarizes the non compensatory equity classified warrant activity for the nine months ended September 30, 2023:

 

   Common Stock 
   Shares   Weighted–
Average
Exercise
Price
   Range of
Exercise Price
   Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2022   10,941   $987.97   $66.00 — $1,000.00    0.33 
Granted                
Exercised                
Expired   (9,114)  $1,000.00   $1,000.00 — $1,000.00     
Forfeited                
Total outstanding – September 30, 2023   1,827   $927.91   $66.00—$1,000.00    0.33 
Exercisable   1,827   $927.91   $66.00—$1,000.00    0.33 
Non-Exercisable